2022 - Research.com Best Scientist Award
2022 - Research.com Medicine in Germany Leader Award
The scientist’s investigation covers issues in Cancer research, Pathology, Glioma, Astrocytoma and IDH1. His research integrates issues of Immunohistochemistry, Mutation, ATRX, Loss of heterozygosity and Tumor suppressor gene in his study of Cancer research. Andreas von Deimling combines subjects such as DNA methylation and Gene expression profiling with his study of Pathology.
His work deals with themes such as Histone, Methylation, Bioinformatics and Histopathology, which intersect with DNA methylation. His Glioma study integrates concerns from other disciplines, such as Internal medicine, CD8 and Oncology. His Oligodendroglioma research focuses on Molecular biology and how it relates to Mutant.
Cancer research, Pathology, Glioma, DNA methylation and Internal medicine are his primary areas of study. His study in Cancer research is interdisciplinary in nature, drawing from both Mutation, Tumor suppressor gene, Gene, Carcinogenesis and Loss of heterozygosity. His Pathology study incorporates themes from Astrocytoma and Oligodendroglioma.
His work in Glioma addresses subjects such as IDH1, which are connected to disciplines such as Isocitrate dehydrogenase and Molecular biology. His DNA methylation research incorporates themes from Methylation and Epigenetics. His research in Internal medicine focuses on subjects like Oncology, which are connected to Temozolomide, Bioinformatics and Cancer.
His primary areas of investigation include Cancer research, DNA methylation, Pathology, Internal medicine and Glioma. His Cancer research study combines topics in areas such as Mutation, Epigenetics, Immune system and GLI2. His research in DNA methylation intersects with topics in Astrocytoma, Methylation, CDKN2A and Copy-number variation.
His work on Pathology is being expanded to include thematically relevant topics such as Mutation. The Internal medicine study combines topics in areas such as Glioblastoma, Oncology and MEDLINE. The study incorporates disciplines such as Cytotoxic T cell, Isocitrate dehydrogenase, Chemotherapy and Wild type in addition to Glioma.
His scientific interests lie mostly in DNA methylation, Pathology, Cancer research, Internal medicine and MEDLINE. His DNA methylation research incorporates elements of Carcinogenesis, Astrocytoma, Pineoblastoma and Retinoblastoma. He has included themes like Fusion gene and Methylation in his Pathology study.
His studies in Cancer research integrate themes in fields like Immune checkpoint, Papillary tumor and Immune system. The concepts of his Internal medicine study are interwoven with issues in Oncology and Profiling. His study in the field of Diffuse Glioma is also linked to topics like Kappa.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary.
David N. Louis;Arie Perry;Guido Reifenberger;Andreas von Deimling.
Acta Neuropathologica (2016)
Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas.
Daniel J. Brat;Roel G.W. Verhaak;Kenneth D. Aldape;W. K.Alfred Yung.
The New England Journal of Medicine (2015)
Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma
Jeremy Schwartzentruber;Andrey Korshunov;Xiao Yang Liu;David T.W. Jones.
Hotspot mutations in H3F3A and IDH1 define distinct epigenetic and biological subgroups of glioblastoma.
Dominik Sturm;Hendrik Witt;Hendrik Witt;Volker Hovestadt;Dong Anh Khuong-Quang.
Cancer Cell (2012)
An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor
Christiane A. Opitz;Ulrike M. Litzenburger;Ulrike M. Litzenburger;Felix Sahm;Martina Ott.
Type and frequency of IDH1 and IDH2 mutations are related to astrocytic and oligodendroglial differentiation and age: a study of 1,010 diffuse gliomas.
Christian Hartmann;Christian Hartmann;Jochen Meyer;Jörg Balss;David Capper.
Acta Neuropathologica (2009)
Analysis of the IDH1 codon 132 mutation in brain tumors
Jörg Balss;Jochen Meyer;Wolf Mueller;Andrey Korshunov;Andrey Korshunov.
Acta Neuropathologica (2008)
Gene expression-based classification of malignant gliomas correlates better with survival than histological classification.
Catherine L. Nutt;D. R. Mani;Rebecca A. Betensky;Pablo Tamayo.
Cancer Research (2003)
Analysis of BRAF V600E mutation in 1,320 nervous system tumors reveals high mutation frequencies in pleomorphic xanthoastrocytoma, ganglioglioma and extra-cerebellar pilocytic astrocytoma.
Genevieve Schindler;David Capper;David Capper;Jochen Meyer;Wibke Janzarik.
Acta Neuropathologica (2011)
Long-term survival with glioblastoma multiforme
Dietmar Krex;Barbara Klink;Christian Hartmann;Andreas Von Deimling.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: